CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 789249-789416 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T22192","span":{"begin":0,"end":167},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Trials of Eculizumab in other autoimmune conditions are ongoing; however, no trial has yet been conducted in neurological disease, or during an ongoing IVIg treatment."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T1729","span":{"begin":0,"end":167},"obj":"Epistemic_statement"}],"text":"Trials of Eculizumab in other autoimmune conditions are ongoing; however, no trial has yet been conducted in neurological disease, or during an ongoing IVIg treatment."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T311","span":{"begin":0,"end":167},"obj":"Sentence"}],"text":"Trials of Eculizumab in other autoimmune conditions are ongoing; however, no trial has yet been conducted in neurological disease, or during an ongoing IVIg treatment."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T1621","span":{"begin":30,"end":51},"obj":"Phenotype"}],"attributes":[{"id":"A1621","pred":"hp_id","subj":"T1621","obj":"http://purl.obolibrary.org/obo/HP_0002960"}],"text":"Trials of Eculizumab in other autoimmune conditions are ongoing; however, no trial has yet been conducted in neurological disease, or during an ongoing IVIg treatment."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4935","span":{"begin":109,"end":129},"obj":"Disease"},{"id":"T9911","span":{"begin":109,"end":129},"obj":"Disease"}],"attributes":[{"id":"A4935","pred":"mondo_id","subj":"T4935","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A97378","pred":"mondo_id","subj":"T9911","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"}],"text":"Trials of Eculizumab in other autoimmune conditions are ongoing; however, no trial has yet been conducted in neurological disease, or during an ongoing IVIg treatment."}